The use of non face-to-face communication to enhance preventive strategies.
Multiple studies have demonstrated disappointingly low rates of persistence with therapies recommended to reduce cardiovascular risk. Non face-to-face communication has been employed as a strategy to increase the rate of adherence with both pharmacologic and lifestyle modification risk-reduction measures. In addition to the impact on adherence, these interventions have the potential to affect intermediate measures, such as increased access to care, increased patient satisfaction, and decreased resource utilization. Improvement in clinical outcomes is the ultimate measure of success of this intervention.
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003142:Communication; D015709:Correspondence as Topic; D034742:Electronic Mail; D015438:Health Behavior; D006297:Health Services Accessibility / Q000592:standards; D006801:Humans; D020407:Internet; D010349:Patient Compliance / Q000523:psychology*; D010353:Patient Education as Topic; D011322:Primary Prevention / Q000379:methods*; D011369:Professional-Patient Relations; D012051:Reimbursement Mechanisms; D012307:Risk Factors; D040242:Risk Reduction Behavior; D013689:Telephone